Document Detail

Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
MedLine Citation:
PMID:  21536086     Owner:  NLM     Status:  Publisher    
Conjugates of cell-penetrating peptides (CPP) and splice redirecting oligonucleotides (ON) display clinical potential as attested by in vivo experimentation in murine models of Duchenne muscular dystrophy. However, micromolar concentrations of these conjugates are required to obtain biologically relevant responses as a consequence of extensive endosomal sequestration following endocytosis. Recent work from our group has demonstrated that appending stearic acid to CPPs increases their efficiency and that the inclusion of pH titrable entities leads to further improvement. Moreover, these modified CPPs form non covalent complexes with charged ON analogs or siRNAs, which allows decreasing the concentrations of ONs by nearly one log. These modified CPPs and the parent peptides have been compared here in the same in vitro model in terms of cell uptake, trafficking and splicing redirection activity. The increased splicing redirection activity of our modified CPPs cannot be explained by differences in cell uptake but rather by their enhanced ability to escape from endocytic vesicles. Accordingly, a clear correlation between membrane destabilizing activity and splicing redirection was observed using a liposome leakage assay. Studies of cellular trafficking for the most active PF6:ON complexes indicate uptake by clathrin-mediated endocytosis using either FACS cell uptake or a splicing redirection functional assay. Acidification of intracellular vesicles and membrane potential were found important for splicing redirection but not for cell uptake. These results do confirm that the increased potency of PF6:ON complexes is not due to the use of a non endocytic route of cell internalization as proposed for some CPPs.
Fatouma Said Hassane; Rachida Abes; Samir E L Andaloussi; Taavi Lehto; Rannar Sillard; Ulo Langel; Bernard Lebleu
Related Documents :
140586 - Comparison of microtitre plates with flat-bottomed and round-bottomed wells for mixed l...
191536 - Quantitation of antibody-complement mediated lysis of tumor cells.
16442816 - Magnetic resonance imaging of functional schwann cell transplants labelled with magneti...
16342206 - Temporally specific proliferation events are induced in the hippocampus following acute...
16664556 - A role for fructose 2,6-bisphosphate in regulating carbohydrate metabolism in guard cells.
1944296 - Novel insulin promoter- and enhancer-binding proteins that discriminate between pancrea...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-20
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  -     ISSN:  1873-4995     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-5-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
University Montpellier 2, UMR 5235 CNRS, place E. Bataillon, 34095 Montpellier cedex 5, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent ...
Next Document:  The significance of mannose-binding lectin gene polymorphisms on the risk of BK virus coinfection in...